title: Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants.
abstract: Several species belonging to Staphylococcus genus (non Sau/ non Sep species) exhibit increasing abilities as opportunistic pathogens in colonisation of periprosthesis tissues. Here we report on antibiotic resistance of 193 strains, belonging to non Sau/ non Sep species, consecutively collected from orthopedic implant infections in a period of about 40 months. The 193 strains (representing 17% of all staphylococci isolated) were analysed for their antibiotic resistance to 16 different drugs. Five species turned out more prevalent, ranging from 1 to 5%: S. hominis (4.2%), S. haemolyticus (3.7%), S. capitis (2.7%), S. warneri (2.6%), and S. cohnii (1.6%). Among these, the prevalence of antibiotic resistance to penicillins was similar, ranging from 51% to 66%. Conversely, significant differences were observed for all the remaining antibiotics. For S. haemolyticus the resistances to oxacillin and imipenem, the four aminoglycosides and erythromycin were at least twice that of the other three species which were compared. S. warneri was on the contrary the species with the lowest occurrence of resistant strains. Ten species appeared only rarely at the infection sites: S. lugdunensis, S. caprae, S. equorum, S. intermedius, S. xylosus, S. simulans, S. saprophyticus, S. pasteuri, S. sciuri, and S. schleiferi. The behaviours of these species, often resistant to penicillins, were individually analysed. Differences in both the frequencies and the panels of antibiotic resistances observed among the non Sau/ non Sep species: i) suggest that horizontal spreading of resistance factors, if acting, was not sufficient per se to level their bio-diversities; ii) highlight and confirm the worrisome appearance within the Staphylococcus genus of emerging ""new pathogens"", not homogeneous for their virulence and antibiotic resistance prevalence, which deserve to be recognised and treated individually.
authors.affiliation: Research Unit on Implant Infections, Rizzoli Orthopedic Institute, Bologna, Italy. carlarenata.arciola@ior.it
authors.forename: C R
authors.initials: CR
authors.lastname: Arciola
authors.forename: D
authors.initials: D
authors.lastname: Campoccia
authors.forename: Y H
authors.initials: YH
authors.lastname: An
authors.forename: L
authors.initials: L
authors.lastname: Baldassarri
authors.forename: V
authors.initials: V
authors.lastname: Pirini
authors.forename: M E
authors.initials: ME
authors.lastname: Donati
authors.forename: F
authors.initials: F
authors.lastname: Pegreffi
authors.forename: L
authors.initials: L
authors.lastname: Montanaro
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D009985:Orthopedics; D015995:Prevalence; D019736:Prostheses and Implants / Q000382:microbiology*; D013045:Species Specificity; D013203:Staphylococcal Infections / Q000453:epidemiology*; D013210:Staphylococcus / Q000145:classification / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents